Pitt Shield

Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation.

Authors: Lerman I, Bu Y, Singh R, Silverman HA, Bhardwaj A, Mann AJ, Widge A, Palin J, Puleo C, Lim H

The field of bioelectronic medicine has advanced rapidly from rudimentary electrical therapies to cutting-edge closed-loop systems that integrate real-time physiological monitoring with adaptive neuromodulation. Early innovations, such as cardiac pacemakers and deep brain stimulation, paved the way for these sophisticated technologies. This review traces the historical and technological progression of bioelectronic medicine, culminating in the emerging potential of closed-loop devices for multiple disorders of the brain and body. We emphasize both invasive techniques, such as implantable devices for brain, spinal cord and autonomic regulation, while we introduce new prospects for non-invasive neuromodulation, including focused ultrasound and newly developed autonomic neurography enabling precise detection and titration of inflammatory immune responses. The case for closed-loop non-invasive autonomic neuromodulation (incorporating autonomic neurography and splenic focused ultrasound stimulation) is presented through its applications in conditions such as sepsis and chronic inflammation, illustrating its capacity to revolutionize personalized healthcare. Today, invasive or non-invasive closed-loop systems have yet to be developed that dynamically modulate autonomic nervous system function by responding to real-time physiological and molecular signals; it represents a transformative approach to therapeutic interventions and major opportunity by which the bioelectronic field may advance. Knowledge gaps remain and likely contribute to the lack of available closed loop autonomic neuromodulation systems, namely, (1) significant exogenous and endogenous noise that must be filtered out, (2) potential drift in the signal due to temporal change in disease severity and/or therapy induced neuroplasticity, and (3) confounding effects of exogenous therapies (e.g., concurrent medications that dysregulate autonomic nervous system functions). Leveraging continuous feedback and real-time adjustments may overcome many of these barriers, and these next generation systems have the potential to stand at the forefront of precision medicine, offering new avenues for individualized and adaptive treatment.

Introduction

Purpose Transcranial ultrasound stimulation
Study Objective To review the historical and technological progression of bioelectronic medicine and argue for developing closed-loop non-invasive autonomic neuromodulation systems by describing their potential applications, opportunities, and remaining knowledge gaps.

Outcomes and Safety

Summary of Outcomes Closed-loop non-invasive neuromodulation (including focused ultrasound, TMS, and autonomic neurography) can modulate central and peripheral/autonomic nervous system activity and thereby alter immune and inflammatory responses, showing therapeutic promise for conditions such as sepsis and chronic inflammation; however, fully adaptive closed-loop autonomic systems remain undeveloped and face significant technical challenges. The paper does not report experimental testing of specific focused ultrasound parameters.
Safety-related matter The review notes that non-invasive closed-loop neuromodulation may mitigate risks associated with invasive procedures and highlights technical/confounding challenges, but it does not report any specific adverse effects or safety events.

Brain Region

Visualization unavailable

Ultrasound Parameters

Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search